SEC Form 4 · accession 0001193125-26-274287
Medline Inc. · MDLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Douglas P Golwas
Officer — Chief Commercial Officer · 10% Owner
Period of report
Jun 15, 2026
Accepted (ET)
Jun 17, 2026 · 4:44 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0002046386
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Jun 15, 2026 | F | 1,889 | $36.61 | D | 23,899 | D | |
| Class A Common StockF2 | Jun 16, 2026 | M | 100,000 | — | A | 123,899 | D | |
| Class A Common StockF4 | Jun 16, 2026 | S | 61,966 | $36.60 | D | 61,933 | D | |
| Class A Common StockF5 | Jun 16, 2026 | S | 38,034 | $37.05 | D | 23,899 | D | |
| Class B Common StockF6 | Jun 16, 2026 | D | 100,000 | — | D | 365,864 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Units of Medline Holdings, LPF2 | — | Jun 16, 2026 | M | 100,000 | D | — | — | Class A Common Stock | 100,000 | 365,864 | I |
Explanation of responses
- F1Reflects shares withheld to satisfy the Reporting Person's tax liability in connection with the vesting of restricted stock units.
- F2Pursuant to the terms of an exchange agreement, dated as of December 16, 2025, holders have the right to exchange their common units of Medline Holdings, LP ("Common Units") for shares of Medline Inc.'s (the "Issuer") Class A common stock ("Class A Common Stock") on a one-for-one basis, subject to customary conversion rate adjustments for stock splits, stock dividends and reclassifications. These exchange rights do not expire. Such Common Units were held indirectly through Medline Management Aggregator LLC.
- F3Reflects sales effected pursuant to a Rule 10b5-1 trading plan adopted on March 11, 2026.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.98 to $36.9785 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.98 to $37.19 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F6Shares of the Issuer's Class B common stock ("Class B Common Stock") have no economic value and have one vote per share. One share of Class B Common Stock is issued for each Common Unit held. Upon the exchange of Common Units for shares of Class A Common Stock, an equivalent number of shares of Class B Common Stock were automatically cancelled.